Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (Q3)Sep 30, 2025 | (Q2)Jun 30, 2025 | (Q1)Mar 31, 2025 | (FY)Dec 31, 2024 | (Q4)Dec 31, 2024 | (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | -2.00%9.53B | -7.85%9.07B | -3.20%9.09B | 1.07%37.95B | -10.75%8.99B | -1.91%9.73B | 10.38%9.84B | 8.65%9.39B | 2.18%37.55B | 6.07%10.08B |
| Cost of revenue | -0.21%33.47B | 1.34%33.54B | ||||||||
| Gross profit | 11.75%4.48B | 9.74%4.01B | ||||||||
| Operating expense | 10.30%2.93B | 6.13%2.66B | ||||||||
| Selling and administrative expenses | ---- | ---- | ---- | 9.27%3.25B | ---- | ---- | ---- | ---- | 6.31%2.97B | ---- |
| -Selling and marketing expense | ---- | ---- | ---- | 9.75%1.57B | ---- | ---- | ---- | ---- | 7.41%1.43B | ---- |
| -General and administrative expense | ---- | ---- | ---- | 8.82%1.68B | ---- | ---- | ---- | ---- | 5.31%1.54B | ---- |
| Total other operating income | ---- | ---- | ---- | 0.49%316.11M | ---- | ---- | ---- | ---- | 7.81%314.55M | ---- |
| Operating profit | -13.22%385.13M | -6.43%375.79M | 18.71%407.36M | 14.58%1.55B | 17.99%359.55M | 70.14%443.82M | 6.11%401.62M | -15.69%343.16M | 17.60%1.35B | 22.87%304.73M |
| Net non-operating interest income (expenses) | 10.33%-13.06M | 42.20%-14.57M | ||||||||
| Non-operating interest expense | 26.40%3.15M | 54.92%3.38M | 49.89%3.5M | -10.33%13.06M | -9.72%6.06M | -2.66%2.49M | -16.87%2.18M | -12.79%2.33M | -42.20%14.57M | -35.97%6.71M |
| Net investment income | ||||||||||
| Gain(Loss) on financial instruments designated as cash flow hedges | ||||||||||
| Gain(Loss) on derecognition of available-for-sale financial assets | ||||||||||
| Income from associates and other participating interests | -1.16%4.61M | 144.21%1.47M | 137.62%5.29M | 9.87%-4.42M | 168.33%8.3M | 37.69%4.67M | -404.86%-3.33M | -411.69%-14.05M | -143.25%-4.9M | -392.44%-12.14M |
| Special income (charges) | ||||||||||
| Other non-operating income (expenses) | ||||||||||
| Income before tax | -13.32%386.6M | -5.61%373.88M | 25.21%409.15M | 14.95%1.53B | 26.55%361.79M | 70.43%445.99M | 5.58%396.11M | -20.08%326.77M | 17.32%1.33B | 18.29%285.88M |
| Income tax | -8.08%97.38M | -10.49%100.95M | 15.15%108.09M | 13.48%414.03M | -0.75%101.44M | 71.84%105.93M | 14.51%112.78M | -8.42%93.87M | 5.08%364.84M | 9.85%102.21M |
| Net income | -14.95%289.22M | -3.67%272.92M | 29.27%301.06M | 15.50%1.12B | 41.74%260.35M | 70.00%340.06M | 2.39%283.32M | -23.98%232.9M | 22.71%966.78M | 23.57%183.68M |
| Net income continuous operations | -14.95%289.22M | -3.67%272.92M | 29.27%301.06M | 15.50%1.12B | 41.74%260.35M | 70.00%340.06M | 2.39%283.32M | -23.98%232.9M | 22.71%966.78M | 23.57%183.68M |
| Noncontrolling interests | 61.94%7.98M | 6.65%7.39M | 10.17%7.56M | 26.59%30M | 293.82%11.29M | -67.84%4.93M | 602.94%6.93M | 51.40%6.86M | 110.82%23.7M | -31.52%2.87M |
| Net income attributable to the company | -16.08%281.25M | -3.93%265.53M | 29.85%293.5M | 15.22%1.09B | 37.75%249.06M | 81.43%335.13M | 0.25%276.39M | -25.11%226.04M | 21.44%943.08M | 25.17%180.81M |
| Preferred stock dividends | ||||||||||
| Other under preferred stock dividend | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net income attributable to common stockholders | -16.08%281.25M | -3.93%265.53M | 29.85%293.5M | 15.22%1.09B | 37.75%249.06M | 81.43%335.13M | 0.25%276.39M | -25.11%226.04M | 21.44%943.08M | 25.17%180.81M |
| Gross dividend payment | ||||||||||
| Basic earnings per share | -16.02%0.283 | -3.96%0.267 | 29.39%0.295 | 15.28%1.094 | 37.91%0.251 | 81.18%0.337 | 0.00%0.278 | -25.00%0.228 | 21.36%0.949 | 24.66%0.182 |
| Diluted earnings per share | -16.02%0.283 | -3.96%0.267 | 29.39%0.295 | 15.28%1.094 | 37.91%0.251 | 81.18%0.337 | 0.00%0.278 | -25.00%0.228 | 21.36%0.949 | 25.16%0.182 |
| Dividend per share | 10.00%0.22 | 11.11%0.2 | -7.41%0.25 | 12.66%0.89 | 20.00%0.24 | 11.11%0.2 | 20.00%0.18 | 3.85%0.27 | 27.42%0.79 | 0.00%0.2 |
| Accounting Standards | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.